WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
Browse
Translate
Options
News
Login
Help
1. (WO2012064763) COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
PCT Biblio. Data
Description
Claims
National Phase
Notices
Drawings
Documents
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/064763    International Application No.:    PCT/US2011/059810
Publication Date: 18.05.2012 International Filing Date: 08.11.2011
IPC:
A61K 38/19 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
Applicants: NATIONAL JEWISH HEALTH [US/US]; 1400 Jackson Street Denver, Colorado 80206 (US) (For All Designated States Except US).
RICHES, David W. H. [US/US]; (US) (For US Only).
BAMBERG, Alison [US/US]; (US) (For US Only)
Inventors: RICHES, David W. H.; (US).
BAMBERG, Alison; (US)
Agent: HANSON, Roberta Jean; Faegre & Benson LLP 2200 Wells Fargo Center 90 South Seventh Street Minneapolis, Minnesota 55402 (US)
Priority Data:
61/411,813 09.11.2010 US
Title (EN) COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
(FR) COMPOSITIONS ET PROCÉDÉS POUR INDUIRE UNE APOPTOSE CIBLÉE
Abstract: front page image
(EN)Embodiments herein concern compositions and methods for treating a subject having or suspected of developing a pulmonary disorder or cancer. Certain embodiments concern modulating protein tyrosine phosphatase non-receptor type 13 (PTPN13) expression and/or activity in a subject to treat uncontrolled cellular growth in the subject.
(FR)La présente invention concerne, dans des modes de réalisation, des compositions et des procédés pour traiter un sujet ayant ou étant suspecté de développer un trouble ou un cancer pulmonaire. Certains modes de réalisation concernent la modulation de l'expression et/ou de l'activité de protéine tyrosine phosphatase de type non-récepteur 13 (PTPN13) chez un sujet pour traiter une croissance cellulaire incontrôlée chez le sujet.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)